Chapter 7 - THE THREE OTHER CHILDREN
-7
Leo was not the first.
That fact almost destroyed me more than the forged consent.
If he had been first, I might have understood how people convinced themselves they were making desperate decisions in unexplored territory.
But Virelia had seen warnings.
Real children.
Real damage.
Before Leo.
The Phoenix family contacted Mara after the federal investigation became public.
Their daughter, Ana Reyes, was six.
Dilated cardiomyopathy.
Expanded-access VRL-17 nine months before Leo.
Her mother, Sofia, called me personally.
I almost did not answer.
Then I heard:
“My daughter knew Leo.”
I stopped breathing.
“What?”
“They met on a video call.”
Virelia had arranged a “family support” session between expanded-access patients.
I had never been told.
Julian must have participated.
Sofia sent a screenshot.
Leo on one side.
Ana on the other.
Both smiling.
Julian holding the tablet.
The date was during a morning I had gone home to sleep.
Again.
He had built a parallel medical world around our son while telling me I was too exhausted to manage details.
Ana survived.
Barely.
Three weeks after VRL-17, she developed ventricular arrhythmias and required emergency mechanical support.
Eventually transplant.
Her parents were told it reflected disease progression.
“Did you sign consent?” I asked.
“Yes.”
“Were you told another child had serious rhythm problems?”
“No.”
“Financial conflicts?”
“No.”
“Repeat dose?”
“No.”
Ana received one.
Her mother cried.
“If I knew what happened to the boy before her, I would have asked different questions.”
The boy before Ana was Mason Trent.
Nine years old.
Ohio.
Stroke after treatment.
Permanent disability.
His father signed a confidentiality settlement with Virelia after the company paid for long-term rehabilitation.
He initially refused to speak.
Then investigators showed him the internal safety communication.
He changed his mind.
Virelia had learned enough from Mason to flag inflammatory clotting risk.
Yet investor materials minimized it.
Then Ana.
Then a five-year-old named Jonah Sloan in North Carolina.
Jonah died six weeks after treatment.
Official cause:
Progressive cardiomyopathy.
His parents never knew an internal Virelia review classified his arrhythmia as “possibly drug-associated.”
By the time Leo received VRL-17, Virelia had three pediatric cases containing serious signals.
The safety director wanted pause.
Rourke wanted more data.
Dr. Mercer wanted continued expanded use under careful monitoring.
Julian wanted Leo treated.
Why?
That question mattered.
Not legally only.
To me.
Was our son simply the next data point?
Or had Julian truly believed he was saving him?
The answer was horrifying because it was both.
Emails from January, months before Leo’s hospitalization, showed Julian learning about Virelia while evaluating investments.
At the time Leo’s cardiomyopathy was worsening but not immediately terminal.
Julian wrote Rourke:
My son may eventually qualify.
Rourke:
We need experienced sites first.
Julian:
If this works, I want him considered.
That sounded like a father.
Then:
I’m increasing position. Personal conviction.
That sounded like an investor.
The two identities fused.
By March, Leo declined.
Julian pushed Virelia to use him under expanded access.
Dr. Mercer initially resisted.
Too little pediatric data.
Julian insisted.
“Would he have done that if there was no money?” I asked Dr. Patel.
She looked at me sadly.
“I can’t know.”
Neither could I.
Maybe he would have fought just as hard for any experimental chance.
Maybe money amplified certainty.
Maybe investment made him hear every warning as obstruction.
Maybe he told himself profit proved belief.
People rarely commit horrible acts for one clean reason.
That was difficult.
I wanted a villain simple enough to hate.
Julian kept refusing that convenience.
He loved Leo.
And he used him.
Both could be true.
Investigators found something else.
Virelia had a pending acquisition requirement:
At least four evaluable pediatric expanded-access cases.
Meridian wanted a broader safety signal before proceeding.
Leo was the fourth.
That made his treatment financially important.
Rourke wrote:
We need L on therapy before May 6 to include in packet.
Julian replied:
Done.
Consent was forged May 4.
First dose May 4.
The timing was not only medical desperation.
It hit a transaction deadline.
I asked Agent Ruiz:
“Does that make it fraud?”
“Potentially securities fraud, wire fraud, healthcare fraud, conspiracy. Regulators will determine.”
“Does it make it murder?”
“No.”
I hated asking.
I hated wanting a word powerful enough.
The state medical board suspended Dr. Mercer.
Federal prosecutors opened criminal investigation.
Virelia dismissed Rourke.
He claimed rogue employees withheld information.
Then the home backup contradicted him.
A call between Rourke and Julian after Leo’s first adverse rhythm episode:
Rourke:
If this blows before diligence, Meridian walks.
Julian:
It won’t.
Rourke:
How do you know?
Julian:
Because Mercer controls classification.
Rourke:
And your wife?
Julian:
She’s not in the data loop.
Rourke laughed.
“Smart.”
That laugh stayed with me.
Not because Rourke knew my name.
Because he did not need to.
I was simply a mother intentionally kept “out of the data loop.”
Then the fourth family appeared.
Jonah’s mother, Melissa.
She flew to Austin.
We met in Mara’s office.
She carried a photograph of Jonah.
Blond hair.
Missing front tooth.
I carried Leo’s.
For a while, we simply looked at each other’s children.
No legal language.
Then Melissa said:
“They told me I should be grateful he got the drug.”
I felt cold.
“Julian told me I would have said no because I was emotional.”
She laughed bitterly.
“They said mothers have difficulty understanding risk when children are terminal.”
There it was.
A philosophy.
Not just Julian.
Some people around the program believed desperate parents were barriers to medical decision-making.
That expertise could replace consent if fear made parents inconvenient.
Melissa had consented, but she felt pressured.
I had not consented at all.
The Virelia program’s culture treated parental autonomy as an obstacle.
Mara began assembling civil claims.
I initially refused to think about money.
Then Sofia Reyes said:
“Money is how institutions measure pain after they fail to measure risk.”
That changed me.
Not because damages equaled Leo.
Nothing did.
But money could fund care.
Independent research.
Patient advocates.
Legal support.
And it could make concealment expensive.
We formed a joint legal group among affected families.
Not a social club.
Not trauma branding.
Evidence sharing.
The families insisted on separate counsel where conflicts existed.
I liked that.
No one person became spokesperson for everyone.
Then a new whistleblower contacted investigators.
Virelia’s former safety analyst, Hannah Price.
She had resigned two months before Leo’s treatment.
Why?
Because management repeatedly downgraded adverse-event classifications.
She kept copies.
Her emails showed Dr. Mercer and Rourke arguing over the repeat-dose warning.
Mercer had actually supported a strict no-repeat rule initially.
Then Julian’s financial pressure entered.
A March email from Julian:
Expanded-access program must demonstrate flexible rescue pathways. One-dose-only restriction undermines commercial value.
Commercial value.
Not Leo.
Before Leo became the patient, Julian had argued repeat dosing mattered commercially.
That changed the second infusion.
He did not improvise the idea solely from desperate fatherhood.
He had already advocated it as investor strategy.
My stomach turned.
Hannah’s files contained an internal risk matrix.
Repeat dosing after arrhythmia:
UNACCEPTABLE.
Red.
Highest category.
Dr. Patel called me after reviewing it.
“If this matrix was current on the night Leo received dose two, I would never have allowed it.”
“Did Mercer have it?”
“Yes.”
“Julian?”
“He received the safety memo summarizing it.”
“Chloe?”
“Likely.”
I felt tired.
So many people had chances.
One could have stopped.
Chloe did file a report.
Too late.
Mercer objected then complied.
Julian pushed.
Rourke pressured.
Systems failed not because everyone agreed.
Because enough people surrendered one boundary each.
One evening, I returned to Leo’s room.
I had moved back into the house after changing locks and obtaining court orders preventing Julian’s access.
At first I thought living there would destroy me.
Then I realized leaving because Julian wanted me gone felt worse.
I sat beside the red fire truck.
The notebook was evidence now.
Truck returned empty.
I placed it beneath the window.
Then I noticed something inside the toy chest.
Leo’s plastic doctor kit.
He used to put the toy stethoscope against my chest.
“Your heart is loud,” he would say.
I picked it up.
My heart was loud now too.
The next morning, prosecutors charged Julian with additional offenses:
Conspiracy to commit healthcare fraud.
Falsification of medical consent.
Obstruction.
Tampering with records.
Reckless injury to a child investigation remained pending at the state level.
Dr. Mercer was arrested.
Rourke was indicted on fraud-related counts.
The acquisition died completely.
Virelia entered bankruptcy protection.
Julian’s fourteen-million-dollar dream became worthless.
Carroway sued him for the $3.8 million loan.
His assets were frozen.
The mistress was pregnant.
The house was mine.
The investment was gone.
The company was collapsing.
None of it gave me satisfaction.
Then Mara called.
“They found the notary.”
“Amelia Cross?”
“Yes.”
“Did she notarize me?”
“No.”
“Who did she see?”
“A woman on video.”
I froze.
“Who?”
“Someone used your driver’s license image and appeared remotely with altered lighting.”
“Can they identify her?”
Mara hesitated.
“Clara.”
“What?”
“The woman was Chloe.”
I stopped breathing.
Chloe had told me she knew nothing about the house.
Maybe she had not known what she signed.
Maybe she did.
May you like
But the fraud video showed my former best friend appearing before a notary under my identity.
The betrayal had another layer.
